The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Neuronal Damage in Brain Inflammation
Abstract
In contrast to traditional textbook paradigms, recent studies indicate neuronal damage in classic neuroinflammatory diseases of the brain, such as multiple sclerosis or meningitis. In these cases, immune cells invade the central nervous system compartments, accompanied by a massive breakdown of the blood-brain barrier and typical changes of the cerebrospinal fluid. On the other hand, inflammation within the central nervous system is a common phenomenon even in classic noninflammatory brain diseases that are characterized by degeneration or trauma of neuronal structures, such as Alzheimer disease, Parkinson disease, or stroke. In these cases, inflammation is a frequent occurrence but displays different, more subtle, patterns compared with, for example, multiple sclerosis. Concepts for directly protecting neurons and axons in neuroinflammatory diseases may improve the outcome of the patients. In parallel, epidemiological and animal experimental evidences, as well as first clinical trials indicate the benefit of immunomodulatory therapies for classic noninflammatory brain diseases. We review the evidence for inflammatory neuronal damage and its clinical impact in the context of these diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pro-inflammatory cytokines and chemokines secreted into the immediate neurological environment accelerate neuronal injury and eventually neuron death (Aktas et al., 2007; Heckmann et al., 2018; Morales et al.,2014).”
From LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease (2019) · cites this paper as Aktas et al., 2007
Citations
Cites
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
Multiple sclerosis--the plaque and its pathogenesis.
Frohman, E., Racke, M., & Raine, C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,793
Peterson, J. W., Bö, L., Mörk, S., Chang, A., & Trapp, B. D. (2001) · Annals of Neurology · doi:10.1002/ana.1123 · Cited by 1,403 · cited 2×
“In patients with MS, we find early axonal pathological features, correlating with the number of infiltrating immune cells, and “black holes” and focal cortical thinning seen on magnetic resonance imaging, indicating complete tissue loss and death of neuronal cell bodies.(1,2) Evenat early stages ofdisease, cognitive i…”
BackgroundNeuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Interleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992
Prass, K., Meisel, C., Höflich, C., Braun, J., Halle, E., Wolf, T., Ruscher, K., Victorov, I. V., Priller, J., Dirnagl, U., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021098 · Cited by 937
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Subpial Demyelination in the Cerebral Cortex of Multiple Sclerosis Patients
Bø, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., & Mørk, S. J. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.7.723 · Cited by 757
Evidence of Axonal Damage in the Early Stages of Multiple Sclerosis and Its Relevance to Disability
Stefano, N. D., Narayanan, S., Francis, G., Arnaoutelis, R., Tartaglia, M. C., Antel, J. P., Matthews, P. M., & Arnold, D. L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.1.65 · Cited by 505
Cited by
Sorted by citations
The biphasic function of microglia in ischemic stroke
Ma, Y., Wang, J., Wang, Y., & Yang, G.-Y. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.005 · Cited by 655
Heckmann, B. L., Teubner, B. J. W., Tummers, B., Boada-Romero, E., Harris, L., Yang, M., Guy, C. S., Zakharenko, S. S., & Green, D. R. (2019) · Cell · doi:10.1016/j.cell.2019.05.056 · Cited by 503
Gorelick, P. B. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05726.x · Cited by 361
Neurogenesis and Inflammation after Ischemic Stroke: What is Known and Where We Go from Here
Tobin, M. K., Bonds, J. A., Minshall, R. D., Pelligrino, D. A., Testai, F. D., & Lazarov, O. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.130 · Cited by 310
Sun, Y., Koyama, Y., & Shimada, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.903455 · Cited by 304
The Role of Natural Killer Cells in Autoimmune Diseases
Küçüksezer, U. C., Çetin, E. A., Esen, F., Tahralı, İ., Akdeniz, N., Gelmez, M. Y., & Deniz, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.622306 · Cited by 304
Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair
Cai, W., Yang, T., Liu, H., Han, L., Zhang, K., Hu, X., Zhang, X., Yin, K., Gao, Y., Bennett, M. V. L., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2017.10.002 · Cited by 240
Neural stem cell therapy for subacute and chronic ischemic stroke
Boese, A. C., Le, Q.-S. E., Pham, D., Hamblin, M. H., & Lee, J.-P. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0913-2 · Cited by 205
Tumor inflammation-associated neurotoxicity
Mahdi, J., Dietrich, J., Straathof, K. C. M., Roddie, C., Scott, B. J., Davidson, T. B., Prolo, L. M., Batchelor, T. T., Campen, C. J., Davis, K. L., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02276-w · Cited by 176
Neuroprotective Properties of Chitosan and Its Derivatives
Pangestuti, R., & Kim, S. (2010) · Marine Drugs · doi:10.3390/md8072117 · Cited by 178
Fingolimod is a potential novel therapy for multiple sclerosis
Aktaş, O., Küry, P., Kieseier, B. C., & Hartung, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.76 · Cited by 167
Cognitive aspects of frailty: Mechanisms behind the link between frailty and cognitive impairment
Halil, M. G., Kızılarslanoğlu, M. C., Kuyumcu, M. E., Yeşil, Y., & Cruz-Jentoft, A. J. (2014) · The journal of nutrition health & aging · doi:10.1007/s12603-014-0535-z · Cited by 160
Mitochondria and the Link Between Neuroinflammation and Neurodegeneration
Filippo, M. D., Chiasserini, D., Tozzi, A., Picconi, B., & Calabresi, P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100543 · Cited by 158
Microglia inflict delayed brain injury after subarachnoid hemorrhage
Schneider, U. C., Davids, A., Brandenburg, S., Müller, A., Elke, A., Magrini, S., Atangana, E. N., Turkowski, K., Finger, T., Gutenberg, A., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1440-1 · Cited by 155
Pharmacotherapeutic potential of ginger and its compounds in age-related neurological disorders
Choi, J. G., Kim, S. Y., Jeong, M., & Oh, M. S. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.010 · Cited by 155
Lee, J., Jo, D., Park, D., Chung, H. Y., & Mattson, M. P. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.007757 · Cited by 155
CD4+CD25+ Regulatory T Cell Depletion Modulates Anxiety and Depression-Like Behaviors in Mice
Kim, S.-J., Lee, H., Lee, G., Oh, S.-J., Shin, M.-K., Shim, I., & Bae, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042054 · Cited by 130
Zhang, J., Lee, A. C.-Y., Chu, H., Chan, J. F., Fan, Z., Li, C., Liu, F., Chen, Y., Yuan, S., Poon, V. K., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa995 · Cited by 128
PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation
Zolezzi, J. M., Santos, M. J., Candia, S. B., Pinto, C., Godoy, J. A., & Inestrosa, N. C. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12320 · Cited by 123
Badshah, H., Ali, T., Rehman, S. U., Amin, F.-U., Ullah, F., Kim, T. H., & Kim, M. O. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9623-z · Cited by 125
Qin, S., Yang, C., Huang, W., Du, S., Mai, H., Xiao, J., & Lü, T. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.014 · Cited by 120
The role of the blood–CNS barrier in CNS disorders and their treatment
Palmer, A. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.029 · Cited by 124
Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy
Ingwersen, J., Aktaş, O., Küry, P., Kieseier, B. C., Boyко, A., & Hartung, H. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.05.005 · Cited by 113
Recent advances in the mechanisms of neuroinflammation and their roles in neurodegeneration
Niranjan, R. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.07.003 · Cited by 112
Melah, K. E., Lu, S. Y.-F., Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150897 · Cited by 109
The Role of Protein Misfolding and Tau Oligomers (TauOs) in Alzheimer′s Disease (AD)
Mroczko, B., Groblewska, M., & Litman‐Zawadzka, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194661 · Cited by 111
Su, W., Hopkins, S., Nesser, N. K., Sopher, B., Silvestroni, A., Ammanuel, S., Jayadev, S., Möller, T., Weinstein, J., & Garden, G. A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301397 · Cited by 103
Interleukin-6 Serum Levels in Patients with Parkinson’s Disease
Hofmann, K. W., Schuh, A. F. S., Saute, J., Townsend, R., Fricke, D., Leke, R., Souza, D. O., Portela, L. V., Chaves, M. L. F., & Rieder, C. R. M. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9921-z · Cited by 98
Xie, Y., Ba, L., Wang, M., Deng, S., Chen, S., Huang, L., Zhang, M., Wang, W., & Ding, F. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13218 · Cited by 102
Goldstein, B. I., Collinger, K. A., Lotrich, F. E., Marsland, A. L., Gill, M., Axelson, D., & Birmaher, B. B. (2011) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0009 · Cited by 97
Neurovascular abnormalities in humans and mice with Huntington's disease
Lin, C.-Y., Hsu, Y.-H., Lin, M.-H., Yang, T.-H., Chen, H.-M., Chen, Y.-C., Hsiao, H.-Y., Chen, C.-C., Chern, Y., & Chang, C. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.08.019 · Cited by 98
Cellular and physiological functions of C9ORF72 and implications for ALS/FTD
Pang, W., & Hu, F. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15255 · Cited by 95
Li, L., Chao, J., & Shi, Y. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2713-x · Cited by 89
Inflammation and gliosis in neurological diseases – clinical implications
Członkowska, A., & Kurkowska‐Jastrzębska, I. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.09.020 · Cited by 93
The Role of Natural Killer Cells in Multiple Sclerosis and Their Therapeutic Implications
Chanvillard, C., Jacolik, R., Infante‐Duarte, C., & Nayak, R. C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00063 · Cited by 85
Ouyang, Q., Zhao, S. X., Li, S., & Song, C. (2017) · Marine Drugs · doi:10.3390/md15110322 · Cited by 78
T cells in amyotrophic lateral sclerosis
Holmøy, T. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02065.x · Cited by 78
Miller, E. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0653-2_17 · Cited by 78
Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease
Tang, P., Li, C., Li, X., Liu, Y., Liu, P., Hou, C., & Li, R. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/208408 · Cited by 77
Chen, S., Liu, Y., Niu, Y., Xu, Y., Zhou, Q., Xu, X., Wang, J., & Yu, M. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.03.045 · Cited by 76
Beckmann, N., Cannet, C., Babin, A. L., Blé, F., Zurbruegg, S., Kneuer, R., & Dousset, V. (2009) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.16 · Cited by 73
Kulesh, A. A., Евгеньевич, Д. В., Куклина, Е. М., Некрасова, И. В., & Shestakov, V. V. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.02.004 · Cited by 69
Selected acute phase CSF factors in ischemic stroke: findings and prognostic value
Beridze, M., Sanikidze, T. V., Shakarishvilil, R., INTSKIRVELI, N., & Bornstein, N. M. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-41 · Cited by 69
Will anti-amyloid therapies work for Alzheimer's disease?
St George-Hyslop, P. H., & Morris, J. C. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61047-8 · Cited by 69
Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair
Selvaraj, U. M., Poinsatte, K., Torres, V. O., Ortega, S. B., & Stowe, A. M. (2016) · Neurotherapeutics · doi:10.1007/s13311-016-0460-4 · Cited by 63
Huang, M., Gedansky, A., Hassett, C. E., Price, C. L., Fan, T. H., Stephens, R. S., Nyquist, P., Uchino, K., & Cho, S.-M. (2021) · Neurocritical Care · doi:10.1007/s12028-021-01309-x · Cited by 60
Neuroimmune and Inflammatory Signals in Complex Disorders of the Central Nervous System
Liberman, A. C., Trías, E., Chagas, L. D. S., Trindade, P., Pereira, M. D. S., Refojo, D., Hedin‐Pereira, C., & Serfaty, C. A. (2018) · NeuroImmunoModulation · doi:10.1159/000494761 · Cited by 62
Neural Stem Cells for Early Ischemic Stroke
Hamblin, M. H., & Lee, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147703 · Cited by 61
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
Ghosh, A., Manrique‐Hoyos, N., Voigt, A., Schulz, J. B., Kreutzfeldt, M., Merkler, D., & Simons, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022735 · Cited by 60
Inflammation in neurological and psychiatric diseases
Khansari, P. S., & Sperlágh, B. (2012) · Inflammopharmacology · doi:10.1007/s10787-012-0124-x · Cited by 59
The immune response in Taenia solium cysticercosis: protection and injury
Sciutto, E., Chavarría, A., Fragoso, G., Fleury, A., & Larralde, C. (2007) · Parasite Immunology · doi:10.1111/j.1365-3024.2007.00967.x · Cited by 55
Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments
Richardson, B., MacPherson, A., & Bambico, F. R. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100554 · Cited by 57
Yao, Y., Bian, L., Yang, P., Sui, Y., Li, R., Chen, Y.-L., Sun, L., Ai, Q., Zhong, L., & Lü, D. (2019) · Brain Research · doi:10.1016/j.brainres.2019.04.025 · Cited by 52
Chen, Q., Yu, W., Shi, J., Shen, J., Gao, T., Zhang, J., Xi, F., Li, J., & Li, N. (2014) · Journal of Inflammation · doi:10.1186/1476-9255-11-18 · Cited by 53
Neuroprotective strategies following perinatal hypoxia-ischemia: Taking aim at NOS
Albrecht, M., Zitta, K., Groenendaal, F., van Bel, F., & Peeters‐Scholte, C. M. P. C. D. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.02.025 · Cited by 53
The Central Nervous System Contains ILC1s That Differ From NK Cells in the Response to Inflammation
Romero-Suárez, S., Del Rio Serrato, A., Bueno, R. J., Brunotte-Strecker, D., Stehle, C., Figueiredo, C. A., Hertwig, L., Dunay, I. R., Romagnani, C., & Infante-Duarte, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02337 · Cited by 51
Is lithium neuroprotective? An updated mechanistic illustrated review
Ghanaatfar, F., Ghanaatfar, A., Isapour, P., Farokhi, N., Bozorgniahosseini, S., Javadi, M., Gholami, M., Ulloa, L., Coleman‐Fuller, N., & Motaghinejad, M. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12826 · Cited by 55
Larsen, A., Kolind, K., Pedersen, D. S., Doering, P., Pedersen, M. Ø., Danscher, G., Penkowa, M., & Stoltenberg, M. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0448-1 · Cited by 51
Increasing use of cognitive measures in the operational definition of frailty—A systematic review
Azzopardi, R. V., Beyer, I., Vermeiren, S., Petrović, M., Noortgate, N. J. V. D., Bautmans, I., & Gorus, E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.01.003 · Cited by 55
Behavioral effects of zinc oxide nanoparticles on the brain of rats
Rahdar, A., Hajinezhad, M. R., Bilal, M., Askari, F., & Kyzas, G. Z. (2020) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2020.108131 · Cited by 51
Chen, Q., Yu, W., Shi, J., Shen, J., Hu, Y., Gao, T., Zhang, J., Xi, F., Gong, J., Li, J., et al. (2013) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-8-186 · Cited by 50
Role of Hippocampal Lipocalin-2 in Experimental Diabetic Encephalopathy
Bhusal, A., Rahman, M. H., Lee, I., & Suk, K. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00025 · Cited by 48
Frost, P. S., Barros‐Aragão, F. G. Q., da Silva, R. T., Venancio, A. M., Matias, I. C. P., Silva, N. M. L. E., Kincheski, G. C., Pimentel‐Coelho, P. M., Felice, F. G. D., Gomes, F. C. A., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1529-x · Cited by 51
FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway
Ntranos, A., Hall, O. J., Robinson, D. P., Grishkan, I. V., Schott, J. T., Tosi, D. M., Klein, S. L., Calabresi, P. A., & Gocke, A. R. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.03.007 · Cited by 48
Harhausen, D., Sudmann, V., Khojasteh, U., Müller, J. M., Zille, M., Graham, K., Thiele, A., Dyrks, T., Dirnagl, U., & Wunder, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069529 · Cited by 44
Waki, H., Gouraud, S. S., Maeda, M., & Paton, J. F. R. (2008) · Autonomic Neuroscience · doi:10.1016/j.autneu.2008.07.001 · Cited by 44
New developments in understanding and treating neuroinflammation
Infante‐Duarte, C., Waiczies, S., Wuerfel, J. T., & Zipp, F. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0292-0 · Cited by 43
Yang, L., Guo, C., Zhu, J., Feng, Y., Chen, W.-L., Feng, Z.-Z., Wang, D., Sun, S., Lin, W., & Wang, Y. (2017) · Medical Science Monitor · doi:10.12659/msm.904240 · Cited by 43
Dual-Channel Fluorescence Imaging of Hydrogel Degradation and Tissue Regeneration in the Brain
Park, G. K., Kim, S., Kim, K., Das, P., Kim, B., Kashiwagi, S., Choi, H. S., & Hwang, N. S.-Y. (2019) · Theranostics · doi:10.7150/thno.35606 · Cited by 42
Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis
Islam, M. A., Alam, S. S., Kundu, S., Ahmed, S., Sultana, S., Patar, A., & Hossan, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12196311 · Cited by 39
The Dichotomous Role of Inflammation in the CNS: A Mitochondrial Point of View
Vezzani, B., Carinci, M., Patergnani, S., Pasquin, M., Guarino, A., Aziz, N., Pinton, P., Simonato, M., & Giorgi, C. (2020) · Biomolecules · doi:10.3390/biom10101437 · Cited by 40
Kowalczyk, M., Szemraj, J., Bliźniewska, K., Maes, M., Berk, M., Su, K.-P., & Gałecki, P. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.05.022 · Cited by 38
Neuroinflammation of Microglial Regulation in Alzheimer’s Disease: Therapeutic Approaches
Chen, H., Zeng, Y., Wang, D., Li, Y., Xing, J., Zeng, Y., Liu, Z., Zhou, X., & Fan, H. J. (2024) · Molecules · doi:10.3390/molecules29071478 · Cited by 41
Inflammatory cytokines expression in Wilson’s disease
Wu, P., Dong, J., Cheng, N., Yang, R., Han, Y.-S., & Han, Y. (2019) · Neurological Sciences · doi:10.1007/s10072-018-3680-z · Cited by 38
Association of matrix metalloproteinases with MRI indices of brain ischemia and aging
Romero, J. R., Vasan, R. S., Beiser, A., Au, R., Benjamin, E. J., DeCarli, C. S., Wolf, P. A., & Seshadri, S. S. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.004 · Cited by 38
AZP2006, a new promising treatment for Alzheimer’s and related diseases
Callizot, N., Estrella, C., Burlet, S., Henriques, A., Brantis, C., Barrier, M., Campanari, M. L., & Verwaerde, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-94708-1 · Cited by 35
Patel, J. C., Shukla, M., & Shukla, M. (2025) · Cells · doi:10.3390/cells14120918 · Cited by 39
Roles of the kallikrein/kinin system in the adaptive immune system
Schulze‐Topphoff, U., Prat, A., Bäder, M., Zipp, F., & Aktaş, O. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.08.001 · Cited by 35
RETRACTED: Cognitive Frailty: Mechanisms, Tools to Measure, Prevention and Controversy
Fougère, B., Delrieu, J., del Campo, N., Soriano, G., Sourdet, S., & Vellas, B. J. (2017) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2017.03.001 · Cited by 35
RetractedVerma, S., Kumar, M., & Nerurkar, V. R. (2010) · Journal of General Virology · doi:10.1099/vir.0.026716-0 · Cited by 34
Ntranos, A., & LUBLIN, F. D. (2016) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-016-0688-8 · Cited by 38
Schneider, R., Koop, B. E., Schröter, F., Cline, J. E., Ingwersen, J., Berndt, C., Hartung, H., Aktaş, O., & Prozorovski, T. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0117-0 · Cited by 32
Umar, M., Rehman, Y., Ambreen, S., Mumtaz, S. M., Shaququzzaman, M., Alam, M. M., & Ali, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102298 · Cited by 33
Japanese Encephalitis Virus-Infected Macrophages Induce Neuronal Death
Nazmi, A., Dutta, K., Das, S., & Basu, A. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9271-x · Cited by 31
Neurovascular protection by peroxisome proliferator-activated receptor α in ischemic stroke
Boese, A. C., Lee, J., & Hamblin, M. H. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113323 · Cited by 30
Immune regulation of multiple sclerosis
Hartung, H., Aktaş, O., Menge, T., & Kieseier, B. C. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52001-2.00001-7 · Cited by 30
Wang, Y., Plastina, P., Vincken, J., Jansen, R., Balvers, M. G. J., ten Klooster, J. P., Gruppen, H., Witkamp, R. F., & Meijerink, J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00298 · Cited by 31
Mahto, K., Kuwar, O. K., Maloo, A., & Kalia, N. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01846-3 · Cited by 33
Yamagata, A. S., Mansur, R. B., Rizzo, L. B., Rosenstock, T. R., McIntyre, R. S., & Brietzke, E. M. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.010 · Cited by 29
Okeke, O., Elbasheir, A., Carter, S. E., Powers, A. D., Mekawi, Y., Gillespie, C. F., Schwartz, A. C., Bradley, B., & Fani, N. (2022) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2022.05.004 · Cited by 32
Innate Immune-Mediated Neuronal Injury Consequent to Loss of Astrocytes
Darlington, P. J., Podjaski, C., Horn, K. E., Costantino, S., Blain, M., Saikali, P., Chen, Z., Baker, K. A., Newcombe, J., Freedman, M. S., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181772cf6 · Cited by 29
A Dichotomous Role for FABP7 in Sleep and Alzheimer’s Disease Pathogenesis: A Hypothesis
Needham, H., Torpey, G., Flores, C. C., Davis, C. J., Vanderheyden, W. M., & Gerstner, J. R. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.798994 · Cited by 29
Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go?
Rommy von Bernhardi, M. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1248 · Cited by 28
Jankowska-Lech, I., Wasyluk, J., Palasik, W., Terelak-Borys, B., & Grabska‐Liberek, I. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.11.003 · Cited by 28
Aghajanpour, F., Boroujeni, M. E., Jahanian, A., Soltani, R., Ezi, S., Khatmi, A., Abdollahifar, M., Mirbehbahani, S. H., Toreyhi, H., Aliaghaei, A., et al. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00214-z · Cited by 29
Transcriptional and cellular signatures of cortical morphometric remodelling in chronic pain
Martins, D., Dipasquale, O., Veronese, M., Turkheimer, F., Loggia, M. L., McMahon, S., Howard, M. A., & Williams, S. C. R. (2022) · Pain · doi:10.1097/j.pain.0000000000002480 · Cited by 27
Gong, L., Zhu, T., Chen, C., Xia, N., Yao, Y., Ding, J., Xu, P., Li, S., Sun, Z., Dong, X., et al. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105823 · Cited by 27
Pardeshi, R., Bolshette, N. B., Gadhave, K., Arfeen, M., Ahmed, S., Jamwal, R., Hammock, B. D., Lahkar, M., & Goswami, S. K. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00288 · Cited by 23
Zhang, Y., Song, S., Li, H., Wang, X., Song, L., & Xue, J. (2022) · Food & Function · doi:10.1039/d1fo03698j · Cited by 26
Function and therapeutic value of astrocytes in diabetic cognitive impairment
Meng, F., Fu, J., Zhang, L., Guo, M., Zhuang, P., Yin, Q., & Zhang, Y. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105591 · Cited by 26
Metadata
- Authors
- Aktas, O., Ullrich, O., Infante-Duarte, C., Nitsch, R., & Zipp, F.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2007-02-01
- Volume
- 64
- Issue
- 2
- Pages
- 185
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2101296507
- Cited by
- 249
- References
- 31
- Citations by year
- 2026: 12 · 2025: 11 · 2024: 14 · 2023: 16 · 2022: 39 · 2021: 17 · 2020: 13 · 2019: 20 · 2018: 11 · 2017: 13 · 2016: 11 · 2015: 5 · 2014: 9 · 2013: 9 · 2012: 8
- FWCI
- 7.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Keywords
- neuronal injury, neuroinflammation, multiple sclerosis, meningitis, blood-brain barrier disruption, cerebrospinal fluid, Alzheimer's disease, Parkinson's disease, stroke, neuroprotection, immunomodulatory therapy, axonal degeneration
- MeSH terms
- Animals, Encephalitis, Humans, Models, Biological, Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review